Multidimensional Approach in Patients With Severe Cerebral Palsy, Prospective Cohort(MAPCP Cohort)-Offline
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03677843|
Recruitment Status : Recruiting
First Posted : September 19, 2018
Last Update Posted : September 19, 2018
|Condition or disease|
|Cerebral Palsy, Spastic|
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Multidimensional Approach in Patients With Severe Cerebral Palsy, Prospective Cohort(MAPCP Cohort)-Offline|
|Estimated Study Start Date :||October 1, 2018|
|Estimated Primary Completion Date :||December 31, 2021|
|Estimated Study Completion Date :||December 31, 2021|
They are included in GMFCS level 3, 4, 5. and they have diplegia or quadriplegia
- hip adductor and spin muscles electromyography(EMG) test [ Time Frame: once at study, when patient enrolled ]
Use EMG to check the activity of the hip adductor and spine muscles of participants.
This figures will give investigators a look at the association with a hip dislocation.
- Whole spine AP and total Hip AP X-ray photograph [ Time Frame: once at study, when patient enrolled and after once every six months for three years ]Whole spine and total Hip joint are checked with X-ray photograph. and investigators will check the progress of hip dislocation and spinal scoliosis.
- hip adductor muscles pressure meter test [ Time Frame: once at study, when patient enrolled ]Pressures of hip adductors muscles are measured from pressure meter. and This figures will give investigators a look at the association with a hip dislocation.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03677843
|Contact: JuSuk Ryu, M.D, PhDemail@example.com|
|Contact: YulHyeon Park, M.Dfirstname.lastname@example.org|
|Korea, Republic of|
|Seoul National University Bundang Hospital||Recruiting|
|Seongnam, Gyeonggi-do, Korea, Republic of, 463-707|
|Contact: Jusuk Ryu, M.D, PhD +82-31-787-7739 email@example.com|
|Contact: ByoungGon JUNG, BA +82-31-787-8430 firstname.lastname@example.org|